Skip to main content
Brett King, MD, Dermatology, Fairfield, CT

BrettAndrewKingMDPhD

Dermatology • Fairfield, CT

Physician

Join to view full profile

Dr. King is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. King's full profile

Already have an account?

  • Office

    425 Post Road
    2nd Floor
    Fairfield, CT 06824
    Phone+1 203-292-9490
    Fax+1 203-292-9487

Summary

  • I was the first dermatologist to show that a class of medicines called Janus kinase (JAK) inhibitors were effective for treatment of alopecia areata, vitiligo, atopic dermatitis (eczema), granuloma annulare, sarcoidosis, lichen planus, and other disorders. I have advanced the use of oral minoxidil for treatment of male and female pattern hair loss (also called androgenetic alopecia) and other hair loss disorders.


    After completing medical training at Yale School of Medicine, I spent 14 years on the full-time faculty at the Yale School of Medicine before recently transitioning to private practice in order to focus on patient care, clinical research and medical education. I have been an investigator in numerous clinical trials, including those leading to approval of Olumiant, Litfulo and Leqselvi for treatment of alopecia areata. I lecture nationally and internationally and publish extensively.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Dermatology, 2006 - 2009
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 2005 - 2006
  • Yale School of Medicine
    Yale School of MedicineClass of 2005
  • Stanford University
    Stanford UniversityPh.D., Chemistry, 2000
  • University of California, Santa Cruz
    University of California, Santa CruzB.A., Chemistry, 1992

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2009 - 2025
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Patient Care Hero American Academy of Dermatology, 2022
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Mentorship Award Women’s Dermatologic Society, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management  
    Brett A King, Ian W Tattersall, Paul A Gaudio, JAMA
  • Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis  
    Craiglow BG, King BA, J Invest Dermatol, 1/1/2014
  • Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate  
    Levy LL, Urban J, King BA, J Am Acad Dermatol, 1/1/2015
  • Join now to see all

Lectures

  • Alopecia: Work-up and Treatment 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
  • Controversies in Dermatology: Stevens-Johnson Syndrome/TEN 
    Miami Beach, FL - 1/1/2010
  • TEN 2011 
    New York, NY - 1/1/2010
  • Join now to see all

Press Mentions

  • Stopping JAK Inhibitor for Severe Alopecia Areata Led to Hair Loss
    Stopping JAK Inhibitor for Severe Alopecia Areata Led to Hair LossAugust 15th, 2024
  • Withdrawal of Baricitinib Results in Loss of Benefit in Severe Alopecia
    Withdrawal of Baricitinib Results in Loss of Benefit in Severe AlopeciaAugust 14th, 2024
  • Alopecia Areata: What Happens When Baricitinib Responders Stop Treatment?
    Alopecia Areata: What Happens When Baricitinib Responders Stop Treatment?August 14th, 2024
  • Join now to see all

Professional Memberships

Dr. Brett King, Dr. Brett King, MD, Dr. B King, Dr. Brett Andrew King